PT94541B - Processo para a preparacao de complexos de derivados dtpa e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de complexos de derivados dtpa e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT94541B
PT94541B PT94541A PT9454190A PT94541B PT 94541 B PT94541 B PT 94541B PT 94541 A PT94541 A PT 94541A PT 9454190 A PT9454190 A PT 9454190A PT 94541 B PT94541 B PT 94541B
Authority
PT
Portugal
Prior art keywords
tris
triaza
complex
carboxymethyl
represent
Prior art date
Application number
PT94541A
Other languages
English (en)
Portuguese (pt)
Other versions
PT94541A (pt
Inventor
Heribert Schmitt-Willich
Heinz Gries
Gabriele Schuhmann-Giampieri
Hubert Vogler
Johannes Platzek
Hans-Joachim Weinmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6384290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT94541(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT94541A publication Critical patent/PT94541A/pt
Publication of PT94541B publication Critical patent/PT94541B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94—Bismuth compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT94541A 1989-06-30 1990-06-29 Processo para a preparacao de complexos de derivados dtpa e de composicoes farmaceuticas que os contem PT94541B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3922005A DE3922005A1 (de) 1989-06-30 1989-06-30 Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
PT94541A PT94541A (pt) 1991-02-08
PT94541B true PT94541B (pt) 1997-02-28

Family

ID=6384290

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94541A PT94541B (pt) 1989-06-30 1990-06-29 Processo para a preparacao de complexos de derivados dtpa e de composicoes farmaceuticas que os contem

Country Status (24)

Country Link
EP (1) EP0405704B1 (enExample)
JP (1) JP2603357B2 (enExample)
KR (1) KR100190808B1 (enExample)
AT (1) ATE115546T1 (enExample)
AU (1) AU637111B2 (enExample)
CA (1) CA2020142C (enExample)
CZ (1) CZ277926B6 (enExample)
DD (1) DD296276B5 (enExample)
DE (3) DE3922005A1 (enExample)
DK (1) DK0405704T3 (enExample)
ES (1) ES2066113T3 (enExample)
FI (1) FI102168B1 (enExample)
HK (1) HK1002810A1 (enExample)
HU (1) HU210208B (enExample)
IE (1) IE65676B1 (enExample)
IL (1) IL94818A (enExample)
NL (1) NL300182I2 (enExample)
NO (2) NO179203C (enExample)
NZ (1) NZ234295A (enExample)
PT (1) PT94541B (enExample)
RU (1) RU2086554C1 (enExample)
TW (1) TW219356B (enExample)
UA (1) UA27275C2 (enExample)
ZA (1) ZA905129B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011684A1 (de) 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
DE4302287A1 (de) * 1993-01-25 1994-07-28 Schering Ag Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
DE4302289A1 (de) * 1993-01-25 1994-07-28 Schering Ag Verfahren zur Herstellung C-substituierter Diethylentriamine
DE4341724A1 (de) * 1993-12-03 1995-06-08 Schering Ag Halogenaryl-substituierte Metallkomplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
JPH10509734A (ja) * 1994-11-30 1998-09-22 シェリング アクチェンゲゼルシャフト 肝臓及び胆嚢用ｘ線診断薬剤としての金属錯体の使用
TW319763B (enExample) 1995-02-01 1997-11-11 Epix Medical Inc
AU4789096A (en) * 1995-02-09 1996-08-27 Schering Aktiengesellschaft Liposomes containing contrast media for blood pool imaging
DE19507820A1 (de) * 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
JP2759627B2 (ja) * 1995-07-21 1998-05-28 東北大学長 非エステル結合性ｄｔｐａ誘導体およびその製造方法
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
DE19646762B4 (de) * 1996-11-04 2004-05-13 Schering Ag Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren
DE19712012A1 (de) * 1997-03-13 1998-09-24 Schering Ag Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6-9-tris(carboxymethyl)-4-(4- ethoxybenzyl)-undecandisäure
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
KR100749087B1 (ko) * 2006-06-02 2007-08-14 경북대학교 산학협력단 신규한 ｄｔｐａ-비스-아미드 리간드들 및 이들이 결합된가돌리늄 착물
SE533165C2 (sv) * 2008-06-13 2010-07-13 Chemseq Internat Ab Kemikalie och förfarande för komplexbindning av metalljoner, som är minst tvåvärda
EP2338874A1 (en) * 2009-12-16 2011-06-29 Bracco Imaging S.p.A Process for the preparation of chelated compounds
PH12012502427A1 (en) 2010-06-11 2013-02-18 Bayer Ip Gmbh Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist
DE102010023890A1 (de) 2010-06-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecandinsäure und die Verwendung zur Herstellung von Primovist
CN104761461A (zh) * 2014-09-09 2015-07-08 山东富创医药科技有限公司 一种新的钆塞酸二钠中间体的制备方法
WO2017208258A1 (en) * 2016-05-30 2017-12-07 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of gadolinium complex of (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium (gadoxetate disodium)
JP6867639B2 (ja) * 2016-10-11 2021-05-12 学校法人 聖マリアンナ医科大学 非イオン性ヨード造影剤の結合体
EP4059925A1 (en) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft New contrast agent for use in magnetic resonance imaging
EP4335462A1 (en) 2022-09-09 2024-03-13 Bayer AG Contrast agents for use in diagnostic computed tomography imaging
EP4335840A1 (en) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
ES2033433T3 (es) * 1987-07-16 1993-03-16 Nycomed As Procedimiento para preparar acidos aminopolicarboxilicos y sus derivados.
AU617338B2 (en) * 1987-07-16 1991-11-28 Nycomed As Aminopolycarboxylic acids and derivatives thereof
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
KR910000134A (ko) 1991-01-29
IE902299A1 (en) 1991-01-16
EP0405704B1 (de) 1994-12-14
PT94541A (pt) 1991-02-08
NL300182I1 (nl) 2005-06-01
CA2020142A1 (en) 1990-12-31
DD296276B5 (de) 1995-11-02
HU904040D0 (en) 1990-12-28
NO179203B (no) 1996-05-20
DE122004000051I1 (de) 2005-04-21
EP0405704A2 (de) 1991-01-02
CZ277926B6 (en) 1993-06-16
ATE115546T1 (de) 1994-12-15
FI102168B (fi) 1998-10-30
NO2005013I2 (no) 2006-06-19
DE59007987D1 (de) 1995-02-02
AU5802490A (en) 1991-01-03
IL94818A (en) 1996-05-14
NL300182I2 (nl) 2005-08-01
EP0405704A3 (en) 1991-03-27
JPH03215457A (ja) 1991-09-20
ZA905129B (en) 1991-04-24
IE902299L (en) 1990-12-30
HUT54622A (en) 1991-03-28
AU637111B2 (en) 1993-05-20
KR100190808B1 (ko) 1999-06-01
NO902925L (no) 1991-01-02
UA27275C2 (uk) 2000-09-15
TW219356B (enExample) 1994-01-21
FI102168B1 (fi) 1998-10-30
FI903295A0 (fi) 1990-06-29
CA2020142C (en) 2001-04-17
ES2066113T3 (es) 1995-03-01
HU210208B (en) 1995-02-28
NZ234295A (en) 1993-02-25
RU2086554C1 (ru) 1997-08-10
IE65676B1 (en) 1995-11-15
DK0405704T3 (da) 1995-02-20
HK1002810A1 (en) 1998-09-18
IL94818A0 (en) 1991-04-15
JP2603357B2 (ja) 1997-04-23
NO179203C (no) 1996-08-28
CS9003174A2 (en) 1991-11-12
NO902925D0 (no) 1990-06-29
DE122004000051I2 (de) 2011-12-29
DE3922005A1 (de) 1991-01-10

Similar Documents

Publication Publication Date Title
PT94541B (pt) Processo para a preparacao de complexos de derivados dtpa e de composicoes farmaceuticas que os contem
US6039931A (en) Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
AU644639B2 (en) DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production
US4647447A (en) Diagnostic media
AU607456B2 (en) Physiologically tolerable metal complex salts for use in nmr diagnosis
US5362475A (en) Gadolinium chelates for magnetic resonance imaging
TW319763B (enExample)
HK1002810B (en) Dtpa-complexes derivatives, pharmaceutical compositions containing them, their use and process for their preparation
US5885548A (en) Multiply substituted DTPA derivatives and their metal complexes, and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of pharmaceutical agents
US5798092A (en) Derivatized DTPA complexes pharmaceutical agents containing these compounds, their use, and processes for their production
IE913899A1 (en) Mono-N-substituted 1,4,7,10-tetraazacyclododecane¹derivatives, process for their production and pharmaceutical¹agents containing these derivatives
CA2116867C (en) Novel chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same
US5648063A (en) Sterile composition comprising a chelate complex for magnetic resonance imaging
EP3442949A1 (en) Contrast agents
PT95008A (pt) Processo para a preparacao de composicoes para o diagnostico rmn e composicoes farmaceuticas que contem compostos complexos de amidas
JPH08506102A (ja) 誘導体化されたｄｔｐａ錯体、該化合物を含有する薬剤、該化合物の使用及び該化合物の製法
US5843399A (en) DTPA monoamides for MRI
DE19740403C2 (de) Neue Kontrastmittel
SK277828B6 (en) Complex dipa derivatives, pharmaceutical agents containing this compounds, their using and method of their production
AU637052B2 (en) Macrocyclic polyaza compounds containing 5 or 6 rings, process for producing them and pharmaceutical media containing them
MXPA96004695A (en) Quelan compounds

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19961125

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20111125